Prep Phase II (2016-2018)

EC H2020 funds for Euro-BioImaging Preparatory Phase II: Full-speed towards operation (Start on Jan 1st, 2016)

In the scope of the EC call for scientific infrastructure development (INFRADEV-2), Euro-BioImaging (EuBI) was granted € 1.5 Mill for its Preparatory Phase-II, to take the final steps needed to start full operation for open user access. In the framework of this project, the legal documents and contracts that will establish EuBI as a new European Research Infrastructure Consortium called EuBI ERIC, will be finalized and signed by its European member countries and international organizations such as EMBL. By joining the EuBI ERIC, its members put EuBI commonly on the infrastructure map of Europe and open its doors for access and services in imaging technologies to all researchers.

The countries have established the first generation of EuBI Nodes. In this regard, the Preparatory Phase II grant also provides the means to prepare the procedures for including additional Nodes in the future and to identify exciting novel imaging technologies that were developed just recently and may be suitable for open user access as part of EuBI. In Preparatory Phase II, the comprehensive EuBI training program for researchers of all levels, as well as the advanced training for core facility staff are being put in place, and the training sites are being prepared for running first courses upon start of the EuBI ERIC. In parallel, the EuBI partners can now develop and test the concepts for future EuBI Image Data Repositories, which will host and offer access to large-scale, high-quality image data sets of common interest for the scientific community.

Gradually taking over tasks from the EuBI Interim Phase working groups and support staff, the future EuBI Hub is being put in place nad is getting prepared to coordinate all activities at the European level of the EuBI ERIC. In summary, the EC H2020 grant for Preparatory Phase-II paves the way for EuBI to go full speed into operation.



This project has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 688945